KLSE (MYR): YSPSAH (7178)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
2.90
Today's Change
-0.03 (1.02%)
Day's Change
2.88 - 2.95
Trading Volume
64,700
Market Cap
411 Million
NOSH
142 Million
Latest Quarter
31-Mar-2024 [#1]
Announcement Date
21-May-2024
Next Quarter
30-Jun-2024
Est. Ann. Date
22-Aug-2024
Est. Ann. Due Date
29-Aug-2024
QoQ | YoY
69.84% | 27.90%
Revenue | NP to SH
368,035.000 | 40,332.000
RPS | P/RPS
259.46 Cent | 1.12
EPS | P/E | EY
28.43 Cent | 10.20 | 9.80%
DPS | DY | Payout %
10.00 Cent | 3.45% | 35.04%
NAPS | P/NAPS
2.88 | 1.01
QoQ | YoY
8.09% | 4.04%
NP Margin | ROE
11.12% | 9.87%
F.Y. | Ann. Date
31-Mar-2024 | 21-May-2024
Latest Audited Result
31-Dec-2023
Announcement Date
23-Apr-2024
Next Audited Result
31-Dec-2024
Est. Ann. Date
23-Apr-2025
Est. Ann. Due Date
29-Jun-2025
Revenue | NP to SH
354,995.000 | 37,315.000
RPS | P/RPS
250.27 Cent | 1.16
EPS | P/E | EY
26.31 Cent | 11.02 | 9.07%
DPS | DY | Payout %
10.00 Cent | 3.45% | 38.01%
NAPS | P/NAPS
2.79 | 1.04
YoY
8.27%
NP Margin | ROE
10.66% | 9.43%
F.Y. | Ann. Date
31-Dec-2023 | 27-Feb-2024
Revenue | NP to SH
434,512.000 | 55,328.000
RPS | P/RPS
306.33 Cent | 0.95
EPS | P/E | EY
39.00 Cent | 7.43 | 13.45%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
48.27% | 27.9%
NP Margin | ROE
13.09% | 13.54%
F.Y. | Ann. Date
31-Mar-2024 | 21-May-2024
Trailing 4 Quarters | Trailing 8 Quarters | |||
---|---|---|---|---|
Available Quarters | 4 Quarters | 8 Quarters | ||
Continuous Quarters Of Revenue Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Total Positive Profit Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Profit Growth | 2 / 4 | 50.00% | 2 / 8 | 25.00% |
Continuous Quarters Of Adjusted EPS Growth | 2 / 4 | 50.00% | 2 / 8 | 25.00% |
Total Dividend Years | 1 / 4 | 25.00% | 2 / 8 | 25.00% |
Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Average ROE | 2.57% | 2.61% | ||
Average Net Profit Margin | 11.15% | 11.22% |
Last 5 Financial Years | Last 10 Financial Years | |||
---|---|---|---|---|
Available Years | 5 Years | 10 Years | ||
Continuous Quarters Of Revenue Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Total Positive Profit Years | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
Continuous Quarters Of Positive Profit | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
Continuous Quarters Of Profit Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Continuous Quarters Of Adjusted EPS Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Total Dividend Years | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
Continuous Quarters Of Dividend | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
Continuous Quarters Of Dividend Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Continuous Quarters Of Adjusted Dps Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Average ROE | 7.31% | 8.16% | ||
Average Net Profit Margin | 8.30% | 9.30% |
T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
---|---|---|---|---|---|
Revenue | 368,035 | 434,512 | 354,995 | 277,631 | 312,756 |
NP to SH | 40,332 | 55,328 | 37,315 | 25,573 | 26,390 |
Dividend | 14,133 | 0 | 14,182 | 10,917 | 11,952 |
Adjusted EPS | 28.43 | 39.00 | 26.31 | 18.03 | 18.60 |
Adjusted DPS | 10.00 | 0.00 | 10.00 | 7.70 | 8.43 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
---|---|---|---|---|---|
Revenue | 21.61% | 13.64% | 13.64% | 18.06% | 21.32% |
NP to Owner | 69.84% | 27.90% | 27.90% | 37.18% | 39.90% |
Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Adjusted EPS | 69.82% | 27.88% | 27.88% | 37.17% | 39.88% |
Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 3.67% | 17.67% | 32.56% | 22.40% | 38.93% | 56.51% | 6.21% | 13.51% | 27.87% |
NP to Owner | 8.09% | 52.83% | 57.71% | 48.27% | 109.65% | 116.35% | 8.27% | 41.40% | 45.91% |
Dividend | -0.35% | 18.24% | 29.45% | 0.00% | 0.00% | 0.00% | 25.71% | 18.66% | 29.90% |
Adjusted EPS | 8.07% | 52.81% | 57.69% | 48.25% | 109.62% | 116.31% | 8.27% | 41.40% | 45.91% |
Adjusted DPS | 0.01% | 18.67% | 29.92% | 0.00% | 0.00% | 0.00% | 25.71% | 18.66% | 29.90% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
gamblers ? i thought most of us will forget we owned this stock until we received a cheque notice about the dividend . hahaha
2021-09-01 16:19
As i mentioned, hold long term for good profit
Refered to my message on 30/8/21
2021-09-01 16:59
Hold for lomg term.
2 years like that.
You will thanks me.
Just a cup of starbuck belanja me.
2021-09-22 11:31
Guide to Investing in Bursa Healthcare 2022
1. Kotra Industries 2. YSP 3. ???
2022-04-02 21:53
Buy-side has no more idea. They will pump all the healthcare stocks remaining
2022-11-04 11:22
walao ehh..wat happen to YSP
Suddenly surge to fly so high today!! Happy Happy
2022-12-13 12:48
Finally this share has released it's true potential power. I have been waiting years for it to shine
2023-01-03 19:55
Apex Healthcare + YSP + Kotra Industries = Dream Healthcare Portfolio 2023
2023-02-23 16:34
Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$â¬Â£Â¥
Security LastPr PE DY% Divcts ROE ttm-marg
YSPSAH (Pharmaceuticals) 2.35 9.63 3.4 8 9.25 10.3
2023-03-30 17:12
New Production line is started to be operated for the newly acquired factory premise. With the newly operated production line, the company's Revenue YoY % growth will be significantly increased within 2 years.
1 month ago
Hi BullishMarket, from where you aware that New Production line is started to be operated for the newly acquired factory premise?
1 month ago
bought a few at 2.85, acceptable bargain I think considering today open at RM3
1 month ago
https://www.facebook.com/xngyuan/videos/828026755888524?idorvanity=3251240861803724
chenjian sifu commented YSPSAH positively
1 month ago
reasons to buy:
1. recorded highest revenue and profit in 20years
2. organic growth, hold patents (expect to continue deliver good result)
3. DY 3.5% above RM0.11 ex 24/6/24
let's monitor
😎
1 month ago
Yspsah has been all the while being the lowest valuation company against its peers like Ahealth & Dpharma.
1 month ago
https://www.ctee.com.tw/news/20220714700772-439801
永信東南亞控股是台灣本土學名藥製藥廠中,第一家跨國上市的公司。這兩年,受疫情影響,年營收成長仍有3%〜5%。即將來臨的後疫情時代,李芳信預計,自2022年起,公司營收至少有雙位數以上的成長。
3 days ago
Lightofheaven
Hold for long term
The profit is promising
2021-08-30 13:55